PALS1 and nonpapillary renal cell carcinoma: To validate gene signature, we searched expression levels of genes contributing to the risk scores in the GSE76207 (p‐value: 3.05e‐05) and GSE82122 (p‐value: 4.88e‐04) which indicated the significance of MPP5 to ccRCC (Figure 6A).